neurodegenerative diseases

Stanford researchers identify gene fingerprint for brain aging in mice, revealing significant changes in white matter and potential treatments.

Low levels of NPTX2 protein in spinal fluid may predict mild cognitive impairment years before symptoms, offering new treatment targets.

Protein TRIM11, capable of preventing neurodegeneration, emerges as a promising therapeutic target for Alzheimer’s disease.

Espresso compounds may combat Alzheimer’s protein clumping, offering potential neurodegenerative disease treatments. (160 characters)

Scientists decode how the endoplasmic reticulum’s impaired recycling can lead to neurodegenerative diseases.

New Drug Target for Alzheimer’s Disease UncoveredIn a significant breakthrough, scientists have conducted a comprehensive study investigating the interactions between …

Arl8b protein, identified alongside amyloid-beta plaques, shows potential as a biomarker for early detection of Alzheimer’s disease.

MIT study unveils how Tau protein tangles, linked to Alzheimer’s, form and identifies a potential drug target.

Cambridge researchers use HIV drug Maraviroc in mice to enhance brain self-clearing, possibly slowing dementia and Huntington’s disease.

Study reveals link between neurogenesis timing and Alzheimer’s disease, suggesting vulnerabilities may be present from birth.